161 related articles for article (PubMed ID: 34796446)
1. Autophagy-associated HMGB-1 as a novel potential circulating non-invasive diagnostic marker for detection of Urothelial Carcinoma of Bladder.
Singh A; Gupta N; Khandakar H; Kaushal S; Seth A; Pandey RM; Sharma A
Mol Cell Biochem; 2022 Feb; 477(2):493-505. PubMed ID: 34796446
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of small leucine-rich proteoglycans (Decorin, Biglycan and Lumican): Plausible diagnostic marker in urothelial carcinoma of bladder.
Appunni S; Anand V; Khandelwal M; Seth A; Mathur S; Sharma A
Tumour Biol; 2017 May; 39(5):1010428317699112. PubMed ID: 28459201
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive diagnostic potential of microRNA-203 in liquid biopsy of urothelial carcinoma of bladder.
Singh P; Singh A; Gupta N; Raja KD; Singh P; Agarwal S; Sharma A
Mol Cell Biochem; 2022 Sep; 477(9):2173-2182. PubMed ID: 35445913
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer.
de Martino M; Lucca I; Mbeutcha A; Wiener HG; Haitel A; Susani M; Shariat SF; Klatte T
Eur Urol; 2015 Oct; 68(4):552-4. PubMed ID: 26138037
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A
Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996
[TBL] [Abstract][Full Text] [Related]
6. HMGB1 Mediated Inflammation and Autophagy Contribute to Endometriosis.
Huang J; Chen X; Lv Y
Front Endocrinol (Lausanne); 2021; 12():616696. PubMed ID: 33815277
[TBL] [Abstract][Full Text] [Related]
7. Urinary bladder cancer test: a new urinary tumor marker in the follow-up of superficial bladder cancer.
Mungan NA; Vriesema JL; Thomas CM; Kiemeney LA; Witjes JA
Urology; 2000 Nov; 56(5):787-92. PubMed ID: 11068302
[TBL] [Abstract][Full Text] [Related]
8. [Molecular markers for the diagnosis of non-muscle-invasive bladder cancer].
Glybchenko PV; Shakhpazian NK; Ponukalin AN; Zakharova NB
Klin Lab Diagn; 2011 May; (5):16-20. PubMed ID: 21789798
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
10. UBC
Ecke TH; Weiß S; Stephan C; Hallmann S; Barski D; Otto T; Gerullis H
Tumour Biol; 2017 May; 39(5):1010428317701624. PubMed ID: 28468590
[TBL] [Abstract][Full Text] [Related]
11. Serum periplakin as a potential biomarker for urothelial carcinoma of the urinary bladder.
Matsumoto K; Ikeda M; Matsumoto T; Nagashio R; Nishimori T; Tomonaga T; Nomura F; Sato Y; Kitasato H; Iwamura M
Asian Pac J Cancer Prev; 2014; 15(22):9927-31. PubMed ID: 25520130
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the diagnostic accuracy of UBC
Styrke J; Henriksson H; Ljungberg B; Hasan M; Silfverberg I; Einarsson R; Malmström PU; Sherif A
Scand J Urol; 2017 Aug; 51(4):293-300. PubMed ID: 28422550
[TBL] [Abstract][Full Text] [Related]
13. UBC
Ecke TH; Weiß S; Stephan C; Hallmann S; Arndt C; Barski D; Otto T; Gerullis H
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513851
[TBL] [Abstract][Full Text] [Related]
14. Urinary cytology and quantitative BTA and UBC tests in surveillance of patients with pTapT1 bladder urothelial carcinoma.
Babjuk M; Soukup V; Pesl M; Kostírová M; Drncová E; Smolová H; Szakacsová M; Getzenberg R; Pavlík I; Dvorácek J
Urology; 2008 Apr; 71(4):718-22. PubMed ID: 18387400
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the monoclonal UBC-ELISA test and the NMP22 ELISA test for the detection of urothelial cell carcinoma of the bladder.
Mian C; Lodde M; Haitel A; Vigl EE; Marberger M; Pycha A
Urology; 2000 Feb; 55(2):223-6. PubMed ID: 10688083
[TBL] [Abstract][Full Text] [Related]
16. Aurora A Kinase as a diagnostic urinary marker for urothelial bladder cancer.
de Martino M; Shariat SF; Hofbauer SL; Lucca I; Taus C; Wiener HG; Haitel A; Susani M; Klatte T
World J Urol; 2015 Jan; 33(1):105-10. PubMed ID: 24562316
[TBL] [Abstract][Full Text] [Related]
17. Qualitative and quantitative detection of urinary human complement factor H-related protein (BTA stat and BTA TRAK) and fragments of cytokeratins 8, 18 (UBC rapid and UBC IRMA) as markers for transitional cell carcinoma of the bladder.
Babjuk M; Kostírová M; Mudra K; Pecher S; Smolová H; Pecen L; Ibrahim Z; Dvorácek J; Jarolím L; Novák J; Zima T
Eur Urol; 2002 Jan; 41(1):34-9. PubMed ID: 11999463
[TBL] [Abstract][Full Text] [Related]
18. Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder Cancer.
Zhang R; Zang J; Xie F; Zhang Y; Wang Y; Jing Y; Zhang Y; Chen Z; Shahatiaili A; Cai MC; Zhao Z; Du P; Jia S; Zhuang G; Chen H
J Urol; 2021 Oct; 206(4):873-884. PubMed ID: 34061567
[TBL] [Abstract][Full Text] [Related]
19. Comparison of tissue biomarkers between non-schistosoma and schistosoma-associated urothelial carcinoma.
AlHariry NS; El Saftawy EA; Aboulhoda BE; Abozamel AH; Alghamdi MA; Hamoud AE; Khalil Ghanam WAE
Tissue Cell; 2024 Jun; 88():102416. PubMed ID: 38796863
[TBL] [Abstract][Full Text] [Related]
20. Expression of miR-100 as a novel ancillary non-invasive biomarker for early detection of bladder carcinoma.
Qureshi A; Fahim A; Kazi N; Farsi Kazi SA; Nadeem F
J Pak Med Assoc; 2018 May; 68(5):759-763. PubMed ID: 29885177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
